These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22045701)

  • 41. Vitamin D and cancer incidence--letter.
    Weir RE; Borek CG
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1948. PubMed ID: 25183880
    [No Abstract]   [Full Text] [Related]  

  • 42. Increased risk of prostate cancer: vitamin D deficiency or low serum calcium levels?
    Saneei P; Esmaillzadeh A
    Nutr Cancer; 2014; 66(5):914. PubMed ID: 24820253
    [No Abstract]   [Full Text] [Related]  

  • 43. Vitamin D and cancer incidence--letter from Grant.
    Grant WB
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1950. PubMed ID: 25183882
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasma levels of nitrate and risk of prostate cancer: a prospective study--letter.
    Schooling CM
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1637. PubMed ID: 23833123
    [No Abstract]   [Full Text] [Related]  

  • 45. The link between vitamin D and prostate cancer.
    Kanaan Y; Copeland RL
    Nat Rev Cancer; 2022 Aug; 22(8):435. PubMed ID: 35761063
    [No Abstract]   [Full Text] [Related]  

  • 46. Response to the Letter by Pauwels, et al.
    Hawkes CP; Schnellbacher S; Singh R; Levine MA
    J Clin Endocrinol Metab; 2015 Sep; 100(9):L84-5. PubMed ID: 26339746
    [No Abstract]   [Full Text] [Related]  

  • 47. Reply by Authors.
    J Urol; 2017 Mar; 197(3 Pt 1):822-823. PubMed ID: 27992739
    [No Abstract]   [Full Text] [Related]  

  • 48. Updated analysis of vitamin D receptor gene FokI polymorphism and prostate cancer susceptibility.
    Mi YY; Chen YZ; Chen J; Zhang LF; Zuo L; Zou JG
    Arch Med Sci; 2017 Oct; 13(6):1449-1458. PubMed ID: 29181077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin D and prostate cancer survival in veterans.
    Der T; Bailey BA; Youssef D; Manning T; Grant WB; Peiris AN
    Mil Med; 2014 Jan; 179(1):81-4. PubMed ID: 24402990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.
    Jacobs ET; Giuliano AR; Martínez ME; Hollis BW; Reid ME; Marshall JR
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):533-7. PubMed ID: 15225833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
    Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating vitamin D and risk of prostate cancer--letter.
    Schwartz GG
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):246; author reply 247. PubMed ID: 22045701
    [No Abstract]   [Full Text] [Related]  

  • 53. Vitamin D and prostate cancer risk--a less sunny outlook?
    Mucci LA; Spiegelman D
    J Natl Cancer Inst; 2008 Jun; 100(11):759-61. PubMed ID: 18505963
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.